Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by aussyspitzon Mar 18, 2020 11:40am
77 Views
Post# 30821696

IMO the bottom for Liminal is still a ways out.

IMO the bottom for Liminal is still a ways out.For the record I think this is a poor investment. However, if you insist on playing with fire I would recommend you wait between 6 - 9 weeks before investing in this POS.

Peak Covid for North America is expected in 45 days with peak deaths lagging an additional 14 days. I think you will see a bottom for this in late May I would not be suprised to see this drift downward to between $4 and $5 over the next 8 weeks.

I also think their entire timeline of forward looking statements is in serious jeopardy of being delayed and depending on how desperate they are for cash to sustain operations any partnership deal they do manage to negotiate will be negotiated from a postion of weakness and IF it actually comes to fruition may not be on the most favorable terms.

If they are unable to negotiate a partnership they will have to raise funds and that will most likely take the form of further dilution which will put additional downward pressure on the stock.
<< Previous
Bullboard Posts
Next >>